A lung biopsy removes a small piece of lung tissue so a pathologist can examine it under a microscope, and the specific method used depends on where the suspicious area sits inside your chest. There are three broad approaches: a bronchoscopic biopsy threaded through your airway, a needle biopsy guided through your chest wall by a CT scanner, and a surgical biopsy performed through small incisions. Each one feels different, carries different risks, and suits different clinical situations. The choice is rarely yours alone; your pulmonologist, radiologist, or surgeon will recommend a route based on the size and location of the lesion, your lung function, and what questions the tissue needs to answer.
Why a Lung Biopsy Gets Ordered
Most lung biopsies happen because imaging turned up something that cannot be diagnosed any other way. A CT scan might show a solitary nodule, a patchy area of consolidation, enlarged lymph nodes in the center of your chest, or widespread scarring that suggests an interstitial lung disease. In each case, the scan tells doctors something is there but not what it is. Tissue is needed to distinguish cancer from infection, inflammation from fibrosis, or one type of cancer from another. That distinction matters because treatment paths diverge sharply depending on what the cells actually show.
Doctors do not jump straight to biopsy for every abnormal finding. Small nodules are often tracked with repeat scans over months to see whether they grow. But when a lesion is large enough, growing, or sitting in a spot that raises suspicion, the calculus shifts. In carefully selected patients, biopsy yields a definitive diagnosis roughly two-thirds of the time and changes the management plan in about a third of cases.1SAGE Journals. Lung biopsy strategies for childhood interstitial lung disease: Indications and techniques Those numbers underscore why the decision to biopsy is deliberate: the procedure is worth the risk only when there is a reasonable chance it will change what happens next.
Bronchoscopic Biopsy Through the Airway
In a bronchoscopic biopsy, a thin flexible scope is guided down your throat and into the branching airways of your lungs. You are typically sedated, sometimes under general anesthesia for more complex procedures. A camera on the tip lets the doctor navigate toward the target, and small instruments passed through a channel in the scope snip or grab bits of tissue. For lesions sitting right along the airway wall, this is straightforward. For lesions deeper in the lung, the doctor needs guidance technology to reach the right spot.
Endobronchial ultrasound, or EBUS, is one of the most widely used guidance tools. A miniature ultrasound probe on the bronchoscope produces real-time images of structures just beyond the airway wall. This is especially useful for sampling enlarged lymph nodes in the center of the chest, a step that is critical for staging lung cancer. EBUS-guided needle aspiration has become a standard method for reaching those nodes without surgery.2PubMed Central. Endobronchial ultrasound: A new innovation in bronchoscopy Adding a forceps biopsy to the needle aspiration can improve diagnostic results, particularly when the suspected disease is something other than cancer.3PubMed Central. Assessment of endobronchial ultrasound-guided bronchoscopy (EBUS) intranodal forceps biopsy added to EBUS 19-gauge transbronchial needle aspiration
For peripheral lesions far out in the lung, a radial ultrasound probe can be advanced through a guide sheath to confirm the catheter is sitting inside the target before samples are taken.4PubMed Central. Comparison of diagnostic yield between electromagnetic navigation bronchoscopy-guided forceps biopsy and target-fixing technique-assisted RP-EBUS-guided transbronchial cryobiopsy with a guide sheath for peripheral lung lesions The advantage of all these bronchoscopic approaches is that they work from inside the airway and avoid puncturing the chest wall, which generally means a lower rate of complications like pneumothorax.
Transbronchial Cryobiopsy
A newer refinement of the bronchoscopic approach uses extreme cold instead of traditional forceps. A cryoprobe is advanced through the bronchoscope, pressed against the tissue, and rapidly cooled. The tissue freezes to the probe tip and is pulled free in one piece. The samples are larger and better preserved than what standard forceps produce, which gives pathologists more architecture to examine. This matters a great deal for interstitial lung diseases, where the pattern of tissue damage, not just the cell types, determines the diagnosis.
Across published case series and small trials, cryobiopsy achieves a diagnostic yield in the range of 70 to 80 percent for diffuse lung disease.5PubMed Central. Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges In a prospective trial that tested different freezing times, about 94 percent of patients had tissue samples judged sufficient for a confident diagnosis.6PubMed. Evaluation of Transbronchial Lung Cryobiopsy Freezing Time, Biopsy Size, Histological Quality, and Incidence of Complication Another benefit is that the frozen tissue retains a high proportion of live cells, which opens the door to specialized testing like flow cytometry when doctors suspect conditions such as lymphoma.7PubMed. Viability and diagnostic potential of tissues obtained through cryobiopsy
Cryobiopsy is not risk-free. Bleeding is the main concern because the probe tears tissue rather than cutting it cleanly. But for many patients with suspected interstitial lung disease, it has become a credible first step before considering a full surgical biopsy.
CT-Guided Needle Biopsy Through the Chest Wall
When a lesion sits near the outer edge of the lung, far from the central airways, a needle biopsy through the chest wall is often the most direct route. You lie on a CT scanner table, and the radiologist uses successive scans to plan the needle path. After numbing the skin and deeper tissues with local anesthetic, a needle is advanced between your ribs and into the lesion. You will be awake for this, though you may receive mild sedation to take the edge off. The actual needle insertion usually takes only a few seconds, and the entire procedure is typically finished within 30 to 45 minutes.
Two needle techniques exist. A core biopsy uses a slightly larger needle that retrieves a slender cylinder of tissue, while a fine-needle aspiration uses a thinner needle that draws out individual cells. Core biopsies are more common because they provide more tissue for the pathologist to work with.8PubMed Central. CT-guided transthoracic biopsy: histopathologic results and complication rates A coaxial technique, in which an outer guide needle is placed first and multiple samples are drawn through it, reduces the number of times the chest wall is punctured.9PubMed. Diagnostic yield and complication rates of percutaneous transthoracic CT-guided coaxial needle biopsy in persistent pulmonary consolidation
You will be asked to hold your breath at specific moments so that the lung stays still while the needle is positioned. The radiologist may reposition you once or twice. It is normal to feel pressure or a brief sharp sting when the needle enters the pleura, and some people feel a deep ache when tissue is sampled. Afterward, a follow-up CT scan checks for immediate complications before you leave the table.
Surgical Lung Biopsy
Surgical biopsy is the most invasive option and is usually reserved for situations where bronchoscopic or needle approaches have failed, are not feasible, or where a larger piece of tissue is needed. The most common surgical approach is video-assisted thoracoscopic surgery, or VATS, in which a camera and instruments are inserted through two or three small incisions between the ribs. The surgeon can directly visualize the lung surface and remove a wedge-shaped piece of tissue. VATS has been used for decades for undiagnosed diffuse lung disease, pleural problems, and solitary nodules.10PubMed. Video-assisted thoracoscopic surgery in the diagnosis and treatment of chest diseases
Because surgical biopsy requires general anesthesia and a hospital stay, it carries a heavier burden than the other methods. Research supports a stepwise approach: starting with cryobiopsy through a bronchoscope and escalating to surgery only when the bronchoscopic sample is non-diagnostic. This strategy can achieve diagnostic accuracy on par with upfront surgical biopsy while reducing complications and time in the hospital.11PubMed Central. Transbronchial Lung Cryobiopsy and Awake Video-Assisted Thoracic Surgery in Interstitial Lung Disease: Complementary Roles in a Stepwise Diagnostic Approach Awake VATS, performed under regional anesthesia instead of general, is gaining traction at some centers as a way to lower the anesthesia burden for patients who are not good candidates for full sedation.
The Complication That Comes Up Most Often
Pneumothorax, a partial collapse of the lung caused by air leaking into the space between the lung and chest wall, is the most common complication of CT-guided needle biopsies. Across large studies, the overall rate runs roughly 15 to 23 percent, though only a fraction of those cases are serious enough to require a chest tube. In a study of 822 biopsies, about 15 percent developed a pneumothorax, and roughly one in five of those needed a tube to drain the air.12Polish Journal of Radiology. Risk factors of pneumothorax and chest tube placement after computed tomography-guided core needle biopsy of lung lesions A larger series of over 2,300 patients found a pneumothorax rate of about 23 percent, with around 8 percent of all patients needing a chest tube.13PubMed Central. Pneumothorax with prolonged chest tube requirement after CT-guided percutaneous lung biopsy: incidence and risk factors
Several factors push the risk higher. Smaller lesions require more precise needle placement and more passes. A deeper lesion means the needle crosses more aerated lung. Emphysema makes the lung tissue more fragile and more likely to leak air. If the needle path crosses a fissure between lung lobes, risk also rises.12Polish Journal of Radiology. Risk factors of pneumothorax and chest tube placement after computed tomography-guided core needle biopsy of lung lesions Being older than 60 and having severe emphysema are independent predictors of needing a chest tube.14PubMed Central. Development and validation of a risk nomogram predicting pneumothorax requiring chest tube placement post-percutaneous CT-guided lung biopsy Most pneumothoraxes that do not need a tube resolve on their own within hours to a day or two. When a tube is placed, the median stay is about a day, though a small percentage of patients require drainage for several days or longer.13PubMed Central. Pneumothorax with prolonged chest tube requirement after CT-guided percutaneous lung biopsy: incidence and risk factors
Bleeding After a Lung Biopsy
Some bleeding into the lung tissue around the biopsy site is common and usually clinically insignificant. It shows up on the post-procedure CT as a hazy white area near the needle track. In one series, pulmonary hemorrhage visible on imaging occurred in about 11 percent of patients, but none of those patients developed hemoptysis (coughing up blood) or hemothorax (blood pooling in the chest cavity).15Journal of Research in Clinical Medicine. Pneumothorax and pulmonary hemorrhage frequency and risk factors of computed tomography-guided transthoracic pulmonary biopsy complications As with pneumothorax, smaller lesions carry a higher bleeding risk because the needle is more likely to pass through normal lung parenchyma to reach the target. Coughing up a small amount of blood-tinged sputum in the hours after any lung biopsy is considered normal, but anything more than a few tablespoons warrants immediate medical attention.
What Happens to the Tissue Afterward
Once removed, the tissue goes to a pathology lab where it is fixed, sliced into thin sections, stained, and examined under a microscope. For suspected cancer, the pathologist determines not just whether cancer cells are present but what type they are: adenocarcinoma, squamous cell carcinoma, small cell carcinoma, and so on. This classification shapes every treatment decision that follows.
In lung cancer, the tissue increasingly undergoes molecular testing as well. Labs look for specific gene mutations and protein markers that can be targeted by precision therapies. Techniques range from single-gene assays to broad sequencing panels that scan dozens of genes at once.16European Respiratory Journal. Unravelling the diagnostic pathology and molecular biomarkers in lung cancer These tests require enough viable tissue, which is one reason doctors and pathologists care about sample size and preservation quality. Research has even shown that previously stained slides can be repurposed for genetic sequencing in a pinch, successfully yielding results in over 80 percent of cases.17PubMed. ‘Upcycling pathology’: targeted next-generation sequencing is feasible in re-purposed haematoxylin and eosin and immunostained formalin-fixed paraffin-embedded sections in lung cancer biopsies Turnaround time for basic pathology is often a few days; molecular results can take a week or two longer.
Comparing Diagnostic Accuracy Across Methods
No single biopsy method is best for every situation, and the numbers make the trade-offs concrete. A systematic review and network meta-analysis compared bronchoscopic and percutaneous approaches for pulmonary lesions. The overall pooled diagnostic yield across all methods was about 78 percent. CT-guided needle biopsy ranked highest at roughly 89 percent, followed by robotic-assisted bronchoscopy at about 85 percent, while radial EBUS alone came in lower at around 72 percent. But CT-guided needle biopsy also had the highest complication rate.18European Respiratory Review. Diagnostic yield and safety of diagnostic techniques for pulmonary lesions: systematic review, meta-analysis and network meta-analysis
A direct comparison between robotic-assisted bronchoscopy and CT-guided needle biopsy found nearly identical diagnostic yields (about 88 percent for both). The difference showed up in complications: the needle biopsy group had a complication rate of 17 percent compared to about 4 percent for the robotic bronchoscopy group.19PubMed. Robotic-assisted bronchoscopy versus CT-guided transthoracic biopsy for diagnosis of pulmonary nodules This kind of data is driving interest in advanced bronchoscopic platforms that can reach peripheral lesions with fewer side effects, though access to these systems varies widely between hospitals.
Robotic Bronchoscopy and Emerging Guidance Tools
Robotic bronchoscopy platforms represent the newest tier of technology. These systems use articulating catheters that can bend and steer through the twisting, narrowing airways more precisely than a standard flexible bronchoscope. Electromagnetic navigation maps a virtual path to the lesion using a pre-procedure CT scan, and once the catheter reaches the target, its correct position is confirmed with a combination of imaging tools that overlay the planned path onto live fluoroscopy.20PubMed Central. Robotic Bronchoscopy in Lung Cancer Diagnosis This helps account for the fact that the lung shifts slightly between the planning CT and the actual procedure.
The technology is still relatively young, and availability is concentrated at larger academic medical centers. For patients with small peripheral nodules that would be difficult to reach by conventional bronchoscopy and risky to target with a needle, robotic bronchoscopy fills a useful niche. Whether it will eventually replace CT-guided biopsy more broadly depends on longer-term outcome data and cost considerations, both of which are still being sorted out.
Liquid Biopsy as a Complement
You may hear about “liquid biopsy,” which is a blood draw rather than a tissue sample. It detects fragments of tumor DNA circulating in the bloodstream. This is not a replacement for a tissue biopsy; it is a complement. Tissue biopsy remains the gold standard for initial diagnosis because it provides the full picture of what the cells look like and how they behave. Liquid biopsy is most useful when tissue is hard to get, when a patient is too frail for a procedure, or when doctors want to track how a cancer is responding to treatment over time without repeated invasive biopsies.21PubMed Central. Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Circulating tumor DNA can reveal many of the same genetic mutations that tissue testing identifies, and it has the advantage of capturing tumor material from multiple sites in the body rather than just the one spot that was biopsied.22PubMed Central. Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer In metastatic non-small cell lung cancer, liquid biopsy data is increasingly used alongside tissue results to guide front-line therapy decisions.23PubMed. Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) If your oncologist orders a blood-based test before or after a tissue biopsy, this is why.
What It Costs
The financial spread between biopsy types is surprisingly wide. A U.S. study of lung cancer patients found that median total costs were highest for inpatient surgical biopsies (about $30,000) and lowest for outpatient percutaneous biopsies (about $1,000). Inpatient procedures accounted for less than a third of all biopsies but drove roughly 80 percent of total costs.24PubMed Central. Costs of Biopsy and Complications in Patients with Lung Cancer Out-of-pocket costs vary by biopsy type too: median patient costs for a single percutaneous biopsy ran about $600, bronchoscopic biopsy about $675, and surgical biopsy about $316 (a counterintuitive figure likely skewed by insurance coverage patterns and inpatient cost-sharing structures).25PubMed. Patient out-of-pocket costs for suspicious pulmonary nodule biopsy in lung cancer patients
The stepwise approach mentioned earlier, starting with cryobiopsy and escalating to surgery only when needed, also makes economic sense. A cost-effectiveness analysis found that this strategy saved substantial resources compared to going straight to surgical biopsy, while achieving similar diagnostic accuracy.26Respiratory Research & Clinical Practice. Transbronchial lung cryobiopsy and surgical lung biopsy for interstitial lung diseases: a cost-effectiveness analysis If you are worried about cost, asking your care team whether a less invasive approach could be tried first is a reasonable conversation to have.
Practical Tips for the Day of the Procedure
Regardless of which biopsy type you are having, a few things are universal. You will be asked to stop blood thinners ahead of time, usually several days before, to reduce bleeding risk. Fasting instructions depend on the level of sedation: if you will be under general anesthesia or moderate sedation, expect nothing to eat or drink after midnight the night before. For a CT-guided biopsy under local anesthesia with light sedation, the fasting window may be shorter.
Bring someone to drive you home. Even after a “simple” needle biopsy, you will have been sedated or stressed, and you typically need to wait one to four hours for a post-procedure observation period and chest X-ray to rule out a delayed pneumothorax. Wear comfortable, loose-fitting clothing with a top that opens in the front. Leave jewelry at home. You can expect some soreness at the biopsy site for a day or two afterward, and over-the-counter pain relievers are usually sufficient.
Activity restrictions vary. After a CT-guided or bronchoscopic biopsy, most people return to normal activities within a day or two. After a surgical biopsy, recovery takes longer, typically a week or more depending on whether a chest tube was placed. Your doctor will tell you when to expect preliminary results. Waiting for pathology is often the hardest part of the entire process, and it is perfectly reasonable to ask your team for a timeline so you are not left guessing.